Bluefin Capital Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,474
Closed -$23.5K 174
2023
Q4
$23.5K Buy
+1,474
New +$19.3K ﹤0.01% 163
2023
Q3
Sell
-15,024
Closed -$221K 199
2023
Q2
$259K Buy
+15,024
New +$307K 0.05% 83
2023
Q1
Sell
-120,324
Closed -$2.62M 100
2022
Q4
$2.09M Buy
120,324
+73,000
+154% +$1.54M 0.31% 48
2022
Q3
$1.15M Hold
47,324
0.1% 123
2022
Q2
$1.5M Sell
47,324
-9,142
-16% -$243K 0.17% 96
2022
Q1
$1.97M Buy
+56,466
New +$2.13M 0.18% 83

Other funds holding CYRX

Bluefin Capital Management's CYRX Position: Q1 2024 in Review

Bluefin Capital Management sold out of CryoPort (CYRX) in Q1 2024, closing a stake of 1,474 shares — an estimated $23.5K sold.

Bluefin Capital Management first reported a position in CYRX in Q1 2022 and held it in 6 quarters. The position peaked at $2.09M in Q4 2022. 150 funds tracked by Wall St. Rank hold CYRX as of Q1 2024.

  • Bluefin Capital Management reported no remaining CryoPort position as of Q1 2024 after selling out during the quarter.
  • Bluefin Capital Management sold 1,474 CryoPort shares in Q1 2024, an estimated $23.5K.
  • Bluefin Capital Management first reported a position in CryoPort in Q1 2022 and held it in 6 quarters.
  • Bluefin Capital Management's CryoPort position peaked at $2.09M in Q4 2022.
  • 150 funds tracked by Wall St. Rank held CryoPort as of Q1 2024.

Based on Bluefin Capital Management's 13F filing for Q1 2024, filed 15 May 2024.